G20 Global Pharma Summit Series-Mexico

Researchers are using Artificial intelligence (AI) to speeding up the drug discovery and development processes. These technologies are being explored by start-ups to address a variety of challenges in the pharmaceutical sector, such as manufacturing process automation and optimization, as well as marketing strategies. The identification of patients is an essential step in the process of drug discovery and development, especially when conducting clinical trials. AI can simplify and speed up the identification of eligibility criteria and patient inclusion, as well as the cohort identification process and save time and money.